Kite Pharma (KITE) Posts Q4 Loss of 85c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Kite Pharma (KITE) Posts Q4 Loss of 85c/Share

Jefferies Reiterates Buy on Kite Pharma (KITE) Following a Mixed 4Q - PT to $75

March 1, 2016 9:31 AM EST

Jefferies maintained a Buy rating on Kite Pharma (NASDAQ: KITE), and cut the price target to $75.00 (from $92.00), following the company's 4Q earnings conference call. KITE reported Q4 revenues of $4.9M, coming in ahead of Jefferies' estimate of $4.4M. GAAP EPS of ($0.85) also beat estimates... More

Citi Starts Kite Pharma (KITE) at Buy

February 25, 2016 8:25 AM EST

Citi initiatesd coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $67.00.

For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.

Shares of Kite Pharma closed at $44.97 yesterday.

... More